Lupin, Neopharmed sign licensing pact for Gastro brand Plasil in Brazil, Philippines
Plasil is widely acknowledged for its efficacy in treating nausea, vomiting, and motility disorders.
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2025-12-18 11:53 GMT | Update On 2025-12-18 11:53 GMT
Advertisement
Mumbai: Global pharma major Lupin has announced that its subsidiaries Multicare Pharmaceuticals in the Philippines and MedQuimica in Brazil have signed an exclusive licensing agreement with Neopharmed Gentili S.p.A, an Italian pharmaceutical company, for marketing and promotional rights for the Gastroenterology brand, Plasil (metoclopramide), in their respective markets.
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets. Neopharmed will oversee product supply in the Philippines, ensuring quality and compliance with global standards. In Brazil, production will be shifted to Medquimica’s manufacturing facility.
Read also: Lupin receives positive EMA comittee opinion for eye therapy Ranluspec
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.